|
Volumn 32, Issue 8, 2011, Pages
|
Periprocedural management of patients on dabigatran etexilate treatment
a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
DABIGATRAN ETEXILATE;
TISSUE PLASMINOGEN ACTIVATOR;
WARFARIN;
ANTICOAGULANT THERAPY;
ANTICOAGULATION;
BLEEDING;
BLOOD CLOTTING TEST;
BLOOD CLOTTING TIME;
CREATININE CLEARANCE;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG WITHDRAWAL;
ELECTIVE SURGERY;
EMBOLISM;
ENDOVASCULAR SURGERY;
HEART ATRIUM FIBRILLATION;
HEMOSTASIS;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
LETTER;
PARTIAL THROMBOPLASTIN TIME;
PATIENT DECISION MAKING;
PERIOPERATIVE PERIOD;
RISK FACTOR;
STROKE;
VEIN THROMBOSIS;
ANTITHROMBIN PROTEINS;
BENZIMIDAZOLES;
HEMORRHAGE;
HUMANS;
NEUROSURGICAL PROCEDURES;
PERIOPERATIVE CARE;
POSTOPERATIVE COMPLICATIONS;
PYRIDINES;
|
EID: 80052884591
PISSN: 01956108
EISSN: 1936959X
Source Type: Journal
DOI: 10.3174/ajnr.A2731 Document Type: Letter |
Times cited : (2)
|
References (4)
|